After meeting on Dec 30, SEC couldn’t come to decision on COVID -19 vaccine it has decided to met on Jan 01, 2021 to further review the emergency use applications of Serum and Bharat Biotech. The additional data requested by Drug regulators was presented while Pfizer has asked for more time to make its presentation for the vaccine and the concerned authorities are reviewing the additional data and analysing further information. Meanwhile UK has approved AstraZeneca which is manufactured by Serum in India which further strengthen its case for emergency usage
India drug regulators to meet on Jan 01 to evaluate data
